Bitterroot Bio

Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.


This profile is unclaimed — do you work here? Claim it

Claim it →
Founded
2021
Headcount
12
Open roles
1
Last raised
Series A · Sign in to view